Close Window

Digital Look Email A Friend

GSK to 'vigorously defend' Zantac claims; Haleon says not a party to claims

Published by Michele Maatouk on 12th August 2022

(Sharecast News) - GlaxoSmithKline said on Friday that it would "vigorously defend" all claims related to its discontinued heartburn drug Zantac.

URL: http://www.digitallook.com/dl/news/story/32888459/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.